Biogen Pharmachem Industries share news, announcements and annual reports
Share price at the BSE close on 29 Oct 2026. Previous close ₹0.25.
29 Oct: open ₹0.25, high ₹0.25, low ₹0.24
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr3,446th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 22,13,209
Biogen Pharmachem Industries share news and announcements
511 announcements, routine notices left out, newest first. Page 6 of 11.
Jan 2021
6 Jan · Board meeting
Meeting on 13 Jan 20211 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Oct 2020
30 Oct · Submission Of Half Yearly Disclosure On Related Party Transactions.
22 Oct · Board meeting
Meeting on 30 Oct 2020: quarterly results21 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....19 Oct · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
6 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI Listing Obligations And Disclosure Requirements) Regulations,2015 For The Period From April 1,2020 To September 30,2020.
5 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Sep 2020
21 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....19 Sep · Meeting
7 Sep · Sub: Intimation For Change In Address Of Registrar And Share Transfer Agent (RTA)
Aug 2020
31 Aug · Board meeting
Meeting on 7 Sep 2020: quarterly results25 Aug · Reg. 34 (1) Annual Report
25 Aug · Meeting
Jul 2020
20 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....6 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Jun 2020
29 Jun · Updation Of Directors/Company Secretary Of The Company
24 Jun · Submission Of Half Yearly Disclosure On Related Party Transactions.
22 Jun · Board meeting
Meeting on 24 Jun 2020: audited results
May 2020
16 May · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
6 May · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 05 May · Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period From October, 1, 2019 To March 31, 2020.
Apr 2020
13 Apr · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Feb 2020
Jan 2020
23 Jan · Board meeting
Meeting on 3 Feb 2020: quarterly results17 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....1 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Oct 2019
21 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of The Sebilisting Obligations And Disclosure Requirements) Regulations,2015 For The Period From April 1, 2019 To September 30,2019.
17 Oct · Submission Of Certificate By PCS Under Regulation 40(9) Of The SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015
15 Oct · Board meeting
Meeting on 26 Oct 2019: quarterly results11 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....